Home > Clinical Trials
Check All Search

Saved trials

ACTIVE_NOT_RECRUITING
NCT05660135
Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia
4,000 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Hypertension


Dyslipidemias
ACTIVE_NOT_RECRUITING
NCT05411887
Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab
2,845 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Hyperlipidemias


Hypertension
NOT_YET_RECRUITING
NCT07116239
Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome
60 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (NA)
Nephrotic Syndrome


Hypoalbuminemia
COMPLETED
NCT04284657
Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
1 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Autosomal Dominant Polycystic Kidney Disease
RECRUITING
NCT06262438
CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
60 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Acute Myeloid Leukemia in Children
COMPLETED
NCT06772246
A Study to Evaluate QTc Prolongation With Quizartinib in Healthy Subjects Under Rapid Acceleration of Heart Rate
70 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1)
Healthy Subjects
RECRUITING
NCT07073755
Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd
200 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Metastatic Breast Cancer


Drug Resistance


Hormone Receptor-Positive Breast Cancer


HER2-positive Breast Cancer


Triple-Negative Breast Cancer (TNBC)


Treatment Decisions
RECRUITING
NCT07065435
RC48 Plus Bevacizumab or Pyrotinib in HER2-Positive Metastatic Breast Cancer After T-DXd Failure: A Phase II Study
74 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
HER2 + Breast Cancer